Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma
scientific article published on 11 June 2019
Author/s
author: Georgina V. Long, Stéphane Dalle, Shahneen K Sandhu, Piotr Rutkowski, Paul Lorigan, Alexander C.J. van Akkooi, Alexander M. M. Eggermont, Stefan Suciu, Paolo Antonio Ascierto, James Larkin, Christian U Blank, Dirk Schadendorf, Matteo Carlino
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.